Holen Sie sich die Stockscreener-App
1.74
4.13%
-0.075
Schlusskurs vom Vortag:
$1.815
Offen:
$1.8
24-Stunden-Volumen:
3.40M
Relative Volume:
0.20
Marktkapitalisierung:
$220.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-112.46M
KGV:
-1.061
EPS:
-1.64
Netto-Cashflow:
$-99.89M
1W Leistung:
-11.22%
1M Leistung:
+4.82%
6M Leistung:
+99.54%
1J Leistung:
+65.71%
1-Tages-Spanne:
$1.73
$1.87
1-Wochen-Bereich:
$1.73
$2.03
52-Wochen-Spanne:
$0.1311
$3.29
Vor Biopharma Inc Stock (VOR) Company Profile
Firmenname
Vor Biopharma Inc
Sektor
Branche
Telefon
617-655-6580
Adresse
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Vergleichen Sie VOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
1.74 | 228.03M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | Eingeleitet | Wedbush | Outperform |
| 2022-04-27 | Eingeleitet | Goldman | Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-12-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-03-03 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-02 | Eingeleitet | Goldman | Sell |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 464,421 Shares of Stock - MarketBeat
Reprogrammed Interchange Llc Sells 449,226 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Reprogrammed Interchange Llc Sells 350,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Clinical-Stage Biotech Vor Bio to Showcase Autoimmune Disease Pipeline at Stifel 2025 Virtual Forum - Stock Titan
139,600 Shares in Vor Biopharma Inc. $VOR Acquired by OMERS ADMINISTRATION Corp - MarketBeat
Vor Biopharma (VOR) 10% owners sell $2.46 million in stock - Investing.com
VOR SEC FilingsVor Biopharma Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
We Think Vor Biopharma (NASDAQ:VOR) Needs To Drive Business Growth Carefully - Yahoo Finance
Screener Results Flag Vor Biopharma Inc. as OversoldCPI Data & Weekly Setup with ROI Potential - 뉴스영
How to integrate Vor Biopharma Inc. into portfolio analysis toolsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Risk vs reward if holding onto Vor Biopharma Inc.Gap Up & High Accuracy Investment Signals - Newser
Is Vor Biopharma Inc. likely to announce a buybackMarket Weekly Review & Daily Stock Trend Reports - خودرو بانک
Is Vor Biopharma Inc.’s growth already priced inJuly 2025 Gainers & Safe Entry Momentum Stock Tips - خودرو بانک
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owners sell shares worth $2.77 million - Investing.com
What is Vor Biopharma Inc. s 5 year growth outlookInsider Buying & Fast Exit Strategy with Risk Control - خودرو بانک
How cyclical is Vor Biopharma Inc.’s revenue streamJuly 2025 Trends & Accurate Entry and Exit Point Alerts - خودرو بانک
Measuring Vor Biopharma Inc.’s beta against major indicesStop Loss & Momentum Based Trading Signals - Newser
What’s next for Vor Biopharma Inc. stock priceQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Sector ETF performance correlation with Vor Biopharma Inc.Earnings Summary Report & Long-Term Growth Plans - Newser
Can Vor Biopharma Inc. lead its sector in growthPortfolio Value Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Vor Biopharma shares rise 2.59% premarket after Connect Biopharma's Nasdaq listing. - AInvest
Is Vor Biopharma Inc. gaining market shareSwing Trade & Fast Gaining Stock Strategy Reports - خودرو بانک
Does Vor Biopharma Inc. fit your quant trading modelWeekly Trade Review & Capital Efficient Trading Techniques - Newser
Quantitative breakdown of Vor Biopharma Inc. recent moveOptions Play & High Win Rate Trade Tips - Newser
Is Vor Biopharma Inc. stock overvalued or fairly priced2025 Major Catalysts & Weekly High Return Stock Opportunities - خودرو بانک
Stifel cuts Vor Biopharma stock rating amid clinical and financial concerns - Investing.com Nigeria
Custom strategy builders for tracking Vor Biopharma Inc.2025 Big Picture & Verified Entry Point Signals - Newser
What data driven models say about Vor Biopharma Inc.’s futureShare Buyback & Stock Portfolio Risk Management - Newser
Real time social sentiment graph for Vor Biopharma Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Price momentum metrics for Vor Biopharma Inc. explained2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Is Vor Biopharma Inc. stock a good pick for beginnersJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - خودرو بانک
Vor Biopharma Inc. stock trend outlook and recovery pathMarket Weekly Review & Long-Term Safe Investment Plans - Newser
Using data filters to optimize entry into Vor Biopharma Inc.July 2025 Drop Watch & Verified Technical Trade Signals - Newser
Applying chart zones and confluence areas to Vor Biopharma Inc.Bond Market & Consistent Profit Trade Alerts - Newser
Building trade automation scripts for Vor Biopharma Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Can Vor Biopharma Inc. grow without external fundingJuly 2025 Institutional & Low Risk High Reward Trade Ideas - خودرو بانک
Using flow based indicators on Vor Biopharma Inc.Dividend Hike & Safe Capital Growth Stock Tips - Newser
Trend analysis for Vor Biopharma Inc. this weekEarnings Miss & Long-Term Growth Stock Strategies - Newser
Multi factor analysis applied to Vor Biopharma Inc.July 2025 Earnings & Weekly Top Gainers Trade List - Newser
Does Vor Biopharma Inc. show high probability of reboundJuly 2025 Decliners & Weekly High Potential Stock Alerts - Newser
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vor Biopharma Inc-Aktie (VOR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Sep 09 '25 |
Sale |
2.00 |
449,226 |
898,632 |
34,563,292 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 10 '25 |
Sale |
1.82 |
350,000 |
635,285 |
34,213,292 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 03 '25 |
Sale |
2.00 |
554,612 |
1,107,061 |
36,329,955 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 04 '25 |
Sale |
1.93 |
453,016 |
873,641 |
35,876,939 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 05 '25 |
Sale |
1.97 |
400,000 |
787,280 |
35,476,939 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):